Outcome of relapsed and refractory nodular lymphocyte‐predominant Hodgkin lymphoma: a North American analysis-Reference-Cited by-同舟云学术

Outcome of relapsed and refractory nodular lymphocyte‐predominant Hodgkin lymphoma: a North American analysis

Published:2021-01-31 Issue:3 Volume:192 Page:560-567
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Strati Paolo¹^ORCID,Cheng Phoebe T. M.²^ORCID,Steiner Raphael E.¹,Alcedo Andrade Pedro E.¹,Feng Lei³,Sano Dahlia¹,Rao Veeramaneni A.¹,Singh Prachee¹,Miranda Roberto⁴,Gunther Jillian R.⁵^ORCID,Pinnix Chelsea C.⁵^ORCID,Dabaja Bouthaina S.⁵,Cuglievan Branko⁶,Xing Katharine⁷,Villa Diego²^ORCID,Skinnider Brian⁸,Sehn Laurie H.²,Connors Joseph M²,Nieto Yago⁹^ORCID,Ahmed Sairah¹⁹^ORCID,Lee Hun J.¹^ORCID,Savage Kerry J.²^ORCID

Affiliation:

1. Department of Lymphoma and Myeloma The University of Texas MD Anderson Cancer Center Houston TX USA

2. BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology BC Cancer Vancouver BC Canada

3. Department of Biostatistics The University of Texas MD Anderson Cancer Center HoustonTXUSA

4. Department of Hemato‐Pathology The University of Texas MD Anderson Cancer Center HoustonTXUSA

5. Department of Radiation Oncology The University of Texas MD Anderson Cancer Center HoustonTXUSA

6. Department of Pediatric Oncology The University of Texas MD Anderson Cancer Center Houston TX USA

7. Department of Medical Oncology British Columbia Cancer Center VancouverBCCanada

8. Department of Pathology British Columbia Cancer Center Vancouver BC Canada

9. Department of Stem Cell Transplantation and Cellular Therapy The University of Texas MD Anderson Cancer Center Houston TX USA

Funder

NIH Clinical Center

Lymphoma Research Foundation

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17281

Reference31 articles.

1. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

2. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

3. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Network N.C.C. Hodgkin Lymphoma (Version 2.2019).https://www.nccn.org/professionals/physician_gls/pdf/hodgkins.pdf

5. Lymphocyte-Predominant and Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies;Blood;2023-08-10

2. Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?;Cancers;2023-06-23

3. Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment;Expert Review of Hematology;2023-06-20

4. Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi;HemaSphere;2023-04

5. Behandlung des nodulär Lymphozyten-prädominanten Hodgkin Lymphoms;Die Onkologie;2022-04-14